Jurisdictions

Issuance Jurisdictions Compared

Switzerland, Luxembourg, Guernsey and Cayman, side by side on the eight things that actually decide the choice — plus Ireland as the external reference point most buyers are really weighing a securitised route against.

The jurisdiction question is usually asked too early. It is downstream of two other answers: who the investors are and where they hold their assets, and what the strategy needs the vehicle to be able to hold. Settle those and the jurisdiction narrows to one or two candidates on its own.

Four of the five columns below are jurisdictions Noray issues from. Ireland is included because it is the alternative buyers most often have in mind when they ask about a listed or white-label product — and because the comparison between a regulated fund route and a securitised route is more useful than a comparison between four securitisation jurisdictions that mostly agree with each other.

Timelines are indicative and measured from signed mandate to first ISIN. They assume onboarding documentation arrives promptly, which is the single variable that moves them most. Not sure which vehicle? →

The comparison matrix

Issuance jurisdictions compared on vehicle types, segregation mechanism, regulatory status, investor eligibility, listing options, settlement venues, typical setup timeline and best-fit use cases.
 SwitzerlandLuxembourgGuernseyCayman IslandsIreland (comparison only)Not issued by Noray
Vehicle typesSwiss issuance vehicles issuing certificates and structured notes in series, each series carrying its own terms and identifier.Securitisation undertakings issuing notes, certificates and listed ETPs from ring-fenced compartments under the Securitisation Law of 2004, as amended.Protected cell companies issuing certificates and notes from individual cells; incorporated cell companies where a cell needs its own legal personality.Segregated portfolio companies issuing notes and certificates from individual segregated portfolios; standalone or orphan SPVs for single transactions.Section 110 designated activity companies for securitisation; ICAVs for regulated funds, including the UCITS ETFs that dominate European listed passive products.
Segregation mechanismContractual segregation per series, supported by the collateral or asset-holding arrangement that backs it, rather than a statutory cell.Statutory compartments. Each compartment's assets and liabilities are walled off by law from every other compartment of the same vehicle.Statutory cells. Guernsey company law ring-fences each cell's assets from the liabilities of every other cell and of the core.Statutory segregated portfolios. Each portfolio's assets are ring-fenced by statute from the creditors of every other portfolio.Segregation by separate legal entity for a Section 110 company, or by sub-fund for an umbrella ICAV. Not a cell mechanism.
Regulatory statusIssuance into Switzerland is governed by FinSA/FIDLEG; a certificate placed with qualified investors relies on the professional-client regime rather than on a retail approval.EU jurisdiction. A securitisation undertaking that does not issue to the public on a continuous basis operates unregulated but within a codified statutory framework; continuous public issuance requires CSSF authorisation.Non-EU, GFSC-supervised. A well-established framework for professional-investor structures, outside the EU regulatory perimeter.Non-EU, CIMA-supervised. Structurally neutral and long familiar to institutional allocators outside Europe.EU jurisdiction, Central Bank of Ireland supervised. A UCITS ETF is a fully regulated retail product with a full authorisation cycle behind it.
Investor eligibilityQualified and professional investors. Retail distribution requires disclosure obligations that a private placement is structured to stay outside of.Professional clients under MiFID II. Retail-facing offers pull in prospectus and PRIIPs obligations that most private placements are structured to avoid.Professional and sophisticated investors. Distribution into the EU is done under each member state's national private placement rules.Professional and institutional investors. European distribution runs under national private placement rules.A UCITS ETF can be distributed to retail investors across the EU — the reason the route exists, and the reason it takes time.
Listing optionsAdmission on the Swiss venue is available for products that need a listing; the majority of Swiss-ISIN certificates are issued unlisted.Regulated-market and exchange-regulated admission available in Luxembourg, and admission on other EU venues where distribution calls for it.Admission available on the local exchange and, where required, on an EU or UK venue; most cells are issued unlisted.Listing is available where a mandate requires one, but the offshore route is chosen for structure rather than for a listing.Admission on the main European venues, which is the norm rather than the exception for products issued from here.
Settlement venuesSIX SIS as the domestic depositary, with links out to the international depositaries for foreign custodians.Euroclear and Clearstream, which is what makes the instrument bookable at effectively any European custodian.Euroclear and Clearstream.Euroclear and Clearstream.Euroclear and the domestic depositaries of the listing venues.
Typical setup timelineApproximately 4–7 weeks to first ISIN.Approximately 5–8 weeks to first ISIN.Approximately 4–6 weeks to first ISIN — the fastest route on the platform.Approximately 4–7 weeks to first ISIN.Months rather than weeks for a UCITS ETF, driven by regulatory authorisation rather than by documentation.
Best-fit use casesA Swiss investor base held at Swiss custodians; discretionary strategies distributed through Swiss private banking relationships; products where a Swiss ISIN is what makes the instrument bookable.EU distribution; credit-linked notes and true-sale securitisations; multi-compartment programmes where several products sit on one vehicle; anything that may later need an EU listing.A first product where speed matters; single-strategy launches; managers who want statutory segregation without an EU nexus.Master–feeder arrangements; investors in Latin America, the Middle East and Asia; digital-asset and alternative strategies whose service providers are already offshore; feeder notes into offshore funds.Index-tracking or rules-based strategies aimed at broad retail distribution across the EU, where a UCITS label is the point of the exercise. Included here as the alternative to weigh a securitised route against — Noray does not issue from Ireland.

Indicative only. Structures are described generically; the entities, agents and service providers involved in any given transaction are set out in that transaction’s own documentation.

When each one is the right answer

Switzerland

A Swiss investor base held at Swiss custodians; discretionary strategies distributed through Swiss private banking relationships; products where a Swiss ISIN is what makes the instrument bookable.

Full guide

Luxembourg

EU distribution; credit-linked notes and true-sale securitisations; multi-compartment programmes where several products sit on one vehicle; anything that may later need an EU listing.

Full guide

Guernsey

A first product where speed matters; single-strategy launches; managers who want statutory segregation without an EU nexus.

Full guide

Cayman Islands

Master–feeder arrangements; investors in Latin America, the Middle East and Asia; digital-asset and alternative strategies whose service providers are already offshore; feeder notes into offshore funds.

Full guide

Ireland (comparison only)

Index-tracking or rules-based strategies aimed at broad retail distribution across the EU, where a UCITS label is the point of the exercise. Included here as the alternative to weigh a securitised route against — Noray does not issue from Ireland.

ETF platform vs ETP issuer

Frequently asked questions

Which jurisdiction is fastest for issuing an AMC or a note?

Guernsey is generally the fastest, at roughly 4–6 weeks from signed mandate to first ISIN, because a new product is a new cell on an existing protected cell company rather than a new entity. Switzerland and Cayman typically run 4–7 weeks and Luxembourg 5–8 weeks. In practice the variable that moves a timeline is rarely the jurisdiction: it is how quickly onboarding documentation on the manager and the sponsoring parties is completed. A jurisdiction with a two-week theoretical edge does not help if KYC takes four weeks longer.

What is the difference between a compartment, a cell and a segregated portfolio?

They are the same idea expressed in three legal systems. A Luxembourg compartment, a Guernsey cell and a Cayman segregated portfolio each ring-fence a defined pool of assets and liabilities inside a single issuing entity, so investors in one product have no exposure to another product on the same vehicle. All three are statutory rather than merely contractual, which is what makes shared issuance infrastructure acceptable to institutional investors. The practical differences are in which courts would enforce the segregation and which regulator supervises the entity, not in the concept.

Do I have to issue from the jurisdiction I am based in?

No, and doing so is one of the more common mistakes. The issuing jurisdiction should follow the investors and the assets, not the manager's own domicile. A Geneva manager selling to EU professional clients is usually better served by an EU-settled compartment; the same manager selling to Latin American family offices through offshore custodians is usually better served by an offshore portfolio. Your own regulatory position matters for how you may market the product, which is a separate question from where it is issued.

Can a product be moved to another jurisdiction after launch?

A live security cannot simply be re-domiciled — its ISIN, terms and settlement arrangements are tied to the issuing vehicle. What is done instead is to issue a new product in the target jurisdiction and migrate investors into it, which is a real exercise with tax and transfer implications for each holder. This is why the jurisdiction question is worth settling before launch rather than after, and why the investor base rather than the manager's convenience should decide it.

Does an EU investor base require an EU jurisdiction?

Not automatically. Non-EU vehicles are routinely distributed to EU professional clients under each member state's national private placement rules, and a Guernsey or Cayman product settles through the same international depositaries as a Luxembourg one. What an EU jurisdiction adds is a shorter distance to an EU listing, familiarity for EU institutional allocators with internal jurisdiction policies, and a simpler answer when a compliance department asks where the issuer sits. If the target buyers are EU institutions rather than EU private clients, that familiarity is often worth more than the extra week or two.

Why is Ireland in this comparison if you do not issue from there?

Because it is the alternative most buyers are actually weighing. When someone asks about a white-label ETF platform, they are usually describing an Irish UCITS ETF: a fully regulated, retail-distributable, index-tracking product with a months-long authorisation cycle behind it. That is a different product from a securitised certificate or note, aimed at a different buyer, and the honest comparison is between the two routes rather than between four securitisation jurisdictions. Including Ireland makes the trade-off visible instead of implying it does not exist.

Can the same strategy be issued from more than one jurisdiction at once?

Yes, and it is a normal arrangement for a manager selling into distinct regions. A strategy can run as a Luxembourg compartment for EU professional clients and as a Cayman segregated portfolio for offshore investors, with the same portfolio management and the same reporting cadence behind both. Each carries its own ISIN and its own documentation, so there are two products to administer rather than one. It is usually worth doing only once a single-jurisdiction product has proved the demand.

Still deciding where to issue from?

Describe the strategy and the investors it is meant to reach, and the structuring team will come back with a jurisdiction and a vehicle, and the reasoning behind both.